NHS England updates CDF List
NHS England updates CDF List
NHS England has updated the Cancer Drugs Fund List. The latest version (v1.353) was uploaded to the NHS England Website on Friday 7, March 2025.
The following changes have been introduced:
Arsenic trioxide in combination with all- trans retinoic acid (ARTA) (ARS5)
Arsenic trioxide in combination with all- trans retinoic acid (ARTA) for the treatment of high-risk acute promyelocytic leukaemia (>=18 years old) where the following criteria are met:
Added to section B of list
Atezolizumab in combination with carboplatin and etoposide (ATE7)
For the first-line treatment of adult patients with extensive-stage small cell lung cancer where the following criteria have been met
Treatment criterion (#13) updated
Durvalumab in combination with gemcitabine and cisplatin (DUR2)
For the 1st line treatment of patients with locally advanced or unresectable or recurrent or metastatic biliary tract cancer where the following criteria have been met
Treatment criteria (#5, 6 and 9) updated